Overview

Study for Patients With Non Small Cell Lung Cancer (NSCLC)

Status:
Unknown status
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
This is a randomized study to assess the efficacy and safety of chemotherapy with platin compared to chemotherapy without platin.
Phase:
Phase 2
Details
Lead Sponsor:
Charite University, Berlin, Germany
Collaborators:
Bristol-Myers Squibb
Pierre Fabre Pharma GmbH
Treatments:
Albumin-Bound Paclitaxel
Carboplatin
Paclitaxel
Vinorelbine